Dr Xand on Visceral Fat
A tape measure can be a useful tool to help measure your waist circumference. The size of your waist can tell you how much fat sits around your abdomen.HOW TO MEASURE YOUR WAISTOn the side of your body, feel for your lowest rib and the top of your hip bone. Find the middle point between them. This will be roughly level with your belly button.Wrap the tape measure around this point.Breathe out naturally, do not hold your tummy in and take your measurement. Repeat it again for accuracy.NHS guidance says 'low risk' waist measurements consist of the following:For white European, black African, Middle Eastern and mixed originMen - 37 inches and belowWomen - 31.5 inches and belowFor African Caribbean, South Asian, Chinese and Japanese origin, the measurements may differ slightly. Men - 35.4 inches and belowWomen - 31.5 inches and belowRemember, these measurements are incredibly strict. Contact your GP if you're concerned. More information can be found on the British Heart Foundation website by clicking here., external
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
22 minutes ago
- BBC News
Brighton man cured of sickle cell disease after NHS transplant
One of the first people in the UK to be cured of sickle cell disease says he now has a "great life".J'rimaya Okojie had a stem cell transplant to treat the genetic blood disorder, which doctors diagnosed him with aged 40 years with the disease, Mr Okojie says he is now the first person with the disease from Brighton to be cured after he was among only a handful of people to get the treatment on the Okojie, known as Jae, told BBC Radio Sussex the difference in his health before and after the treatment was "like night and day". People with sickle cell disease produce unusually shaped red blood cells that do not live as long as healthy blood cells and can block blood vessels, according to the inherited disease is more common in people with an African or Caribbean family of Mr Okojie's sisters died from the Okojie, who works for the NHS, said the disorder "literally shaped my life" and he "missed school almost regularly" as a "crisis episodes" experienced as a result of the disease could last between two hours and two weeks and brought "unexplainable" pain, he said. "Your body just shuts down," he added. Dale Seviar, a consultant at Guy's and St Thomas' NHS Foundation Trust in London, told BBC Radio Sussex the treatment Mr Okojie underwent was "very intensive".Only a few patients are offered the treatment due to the risks involved, he said, but doctors were "finally at a stage where we are speaking to patients more and more about curative treatments".Stem cell transplants were approved for adults in 2019 and gene therapy was approved for NHS use in January, he added.
Telegraph
23 minutes ago
- Telegraph
Trump would be doing Britain a favour by destroying the NHS
Prime Minister Keir Starmer is reportedly on the cusp of selling out our precious NHS to president Donald Trump in exchange for a trade deal. This is, of course, nothing more than hysteria. For better, but likely for worse, the NHS is not going anywhere. All that's actually on the table is a long-running American gripe about how much the UK pays for drugs. The NHS uses its monopsony power (being a single buyer) to negotiate lower pharmaceutical prices. This means Americans are left footing the hefty bill for research and development into revolutionary lifesaving medicines. Trump would like the UK to pay a 'fairer' share. The trade deal could also make it easier for US drug companies to sell cutting-edge treatments to the NHS. This comes after the National Institute of Health and Care Excellence (Nice) has prevented the NHS from purchasing several high-profile therapies, such as Alzheimer's and cancer treatments, over value-for-money concerns. The founding myth of modern Britain is that the NHS represents something particularly unique: an institution worthy of banging saucepans outside our front doors during a pandemic. In fact, universal healthcare is the norm across developed countries. What is special about the NHS is its poor outcomes despite massive public expenditures. There are now over six million people on waiting lists that may never substantially shrink. In 2023, over 117,000 of all deaths in England were deemed avoidable, either through effective public health measures or timely medical intervention. Compared to peer nations, the UK exhibits higher rates of deaths. This is driven by subpar outcomes in cancers, heart attacks and strokes. It would be nice to believe that the NHS is a national asset, one that someone like Trump would want to come in and buy. But in fact, it is an ongoing and growing series of liabilities that no investor would touch with a barge pole. We are now spending a whopping £205 billion annually, larger than the total national income of New Zealand. The public is becoming increasingly aware of this situation. In April, the British Social Attitudes poll found the highest level of dissatisfaction with the NHS since the survey began in 1983. An astonishing 59 per cent of Brits said they were 'very' or 'quite' dissatisfied with the health service. There remains a stubborn hope within the system that yet another injection of taxpayer cash, especially in the form of capital investment, will miraculously reverse the NHS's decline. But this remedy has been applied repeatedly over the years, without measurable improvement. The core dysfunction lies not in funding levels but in the model itself. Healthcare demand is virtually limitless, yet the NHS operates within a rigid, centrally planned structure that lacks the necessary tools to allocate resources efficiently. In the absence of prices, bureaucrats must make arbitrary decisions about who gets treated and when. And without the profit motive, there is scant incentive to innovate, cut waste, or improve service quality. The result is a system defined by delays, inefficiency, and declining outcomes, regardless of the amount of money invested in it. The only way to fix this problem would be to destroy the NHS as we know it. To incorporate greater elements of private sector involvement, competitive pressures and social insurance, which are known to deliver much better outcomes from Germany and Singapore through to Australia. For now, we remain mired in a phoney war, where campaigners rally to defend the NHS against an imagined Trump plot rather than confront the system's deep-rooted failings. Matthew Lesh is Country Manager at Freshwater Strategy and Public Policy Fellow at the Institute of Economic Affairs
Western Telegraph
35 minutes ago
- Western Telegraph
NHS has ‘culture of cover-up' over failures, Health Secretary says
He told MPs there is 'too much of that happening' in the NHS, and that reputations are protected instead of patients being told the truth. The minister's comments came after Labour MP Perran Moon (Camborne and Redruth) told him about the experience of a woman in his constituency who suffered from nerve damage after a hip operation, but was told her pain was 'common'. Mr Moon said: 'A couple of weeks ago at my constituency surgery, through the tears, my constituent Amy explained how, following a hip operation in 2008, she suffered progressive nerve damage due to repeated failures in diagnosis, referral and treatment. We are changing the culture, safety is at the heart of the 10-year plan, and I'd be delighted to talk to him further about his constituent's case Health Secretary Wes Streeting 'Despite raising concerns for years, she was told her pain was common. 'A nerve test in 2015 confirmed damage and further tests last year showed a significant deterioration. After 17 years, she's only now been offered surgery. 'All Amy wants to know is what steps are being taken to ensure that no other patient is left permanently disabled due to such long and systemic failures.' Responding, Mr Streeting said: 'Can I first of all, on behalf of the NHS, apologise to his constituent. 'That is a totally intolerable situation, but sadly not rare or exceptional. 'There's too much of that happening and a culture of cover-up and covering reputations, rather than being honest with patients about failures. 'We are changing the culture, safety is at the heart of the 10-year plan, and I'd be delighted to talk to him further about his constituent's case.' Elsewhere during health and social care oral questions on Tuesday, the Government was challenged on the difficulties that pharmacies are facing. Liberal Democrat MP Caroline Voaden (Lucy North/PA) Liberal Democrat MP Caroline Voaden (South Devon) told MPs the 'current funding model doesn't take into account the lower footfall and the limited referral rates that are common in rural areas'. She said: 'If a pharmacy in a small market town closes, it can cause extreme difficulties for people to access advice and medicines, particularly where there is little or no public transport and they have to go a long way.' Conservative shadow health minister Dr Luke Evans raised the cap on funded consultation appointments that pharmacies can schedule through the Pharmacy First Scheme. He said: 'Once they hit that cap, they are no longer paid the £17 per consultation. 'That, in turn, may mean patients will either be turned away or the pharmacist has to take the hit and has to pay for it themselves.' Care minister Stephen Kinnock replied: 'The pharmacy sector is facing huge challenges after massive cuts over the last 14 years. We're beginning to rebuild, but there are particular challenges for rural pharmacies. 'We are looking at comprehensive reform in the pharmacy sector around better use of technology, hub-and-spoke dispensing and a range of other options which would enable better remote dispensing for rural pharmacies.' He told Dr Evans that the 'record uplift' of £3.1 billion for the pharmacy sector was coming in 'after years of underfunding, incompetence and neglect' from the Conservatives, and that the allocation of funding will be looked at in their reforms.
